comparemela.com

Latest Breaking News On - Investigational therapeutics - Page 1 : comparemela.com

Shifting Therapies to Earlier Settings Could Bolster Treatment Options in mHSPC and Oligometastatic Prostate Cancer

Neeraj Agarwal, MD, FASCO, discusses unmet needs across the prostate cancer spectrum and ongoing trials investigating agents in earlier settings.

United statesNeeraj agarwalCancer researchGenitourinary oncology programCancer conferencePresidential endowed chairInvestigational therapeuticsUtah huntsman cancer instituteSalt lake

Dr Agarwal on QOL Considerations for Patients With Prostate Cancer

Neeraj Agarwal, FASCO, MD, discusses quality of life considerations for patients with prostate cancer.

Neeraj agarwalHuntsman cancer instituteUniversity of utahCancer researchGenitourinary oncology programPresidential endowed chairInvestigational therapeutics

Atezolizumab Plus Cabozantinib Improves PFS Over Novel Hormonal Therapy in mCRPC

A significant progression-free survival improvement was achieved with cabozantinib plus atezolizumab vs second-line novel hormonal therapy in mCRPC.

Neeraj agarwalGlobal health statusUniversity of utahEuropean organization for researchGenitourinary oncology gu programHuntsman cancer instituteGenitourinary oncologyInvestigational therapeuticsEuropean organizationCancer qualityCabozantinib plus atezolizumabMetastatic castration resistant prostate cancer2024 genitourinary cancers symposiumPhase 3 contact 02 trial

Cabometyx, Tecentriq Combo Improves Time to Progression in mCRPC

Cabometyx plus Tecentriq led to improved progression-free survival compared with novel hormonal therapy in patients with metastatic castration-resistant prostate cancer.

Neeraj agarwalCabometyx tecentriqGlobal health statusEuropean organization for researchUniversity of utahGenitourinary oncology gu programHuntsman cancer instituteGenitourinary oncologyInvestigational therapeuticsEuropean organizationCancer qualityGlobal healthProstate cancerMetastatic castration resistant prostate cancerAsco gu24

New Impactful Leadership Roles at Huntsman Cancer Institute

Huntsman Cancer Institute has appointed new roles for Theresa Werner, MD, and Neeraj Agarwal, MD, FASCO.

University of utahUnited statesKarenh huntsmanTheresa wernerNeeraj agarwalNeli ulrichAmerican association of cancer institutesNational cancer instituteTherapeutic accelerator hub committeeCancer clinical investigator team leadership awardDirectors of clinical researchCancer center support grantSociety of huntsman translational scholarsKaren huntsman presidential professor in cancer researchDrug administrationPhysician clinical leadership initiative

vimarsana © 2020. All Rights Reserved.